Using molecular structures to choose the best therapy. Currently focusing on mutations in EGFR and other lung cancer drivers. Working closely with the Molecular Tumor Board at the UMCG #umcg and patient organizations across Europe." title="" class="btn" data-container="body" data-html="true" data-id="241767" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#0077b5" tabindex="0" data-original-title="Protyon"> 537
Activities
Technologies
Entity types
Location
Groningen, Netherlands
Groningen
Netherlands
Employees
Scale: 2-10
Estimated: 8
Engaged corporates
1Added in Motherbase
1 year, 8 months agoGuiding clinicians towards personalized treatment and enhancing quality of life for patients
Using molecular structures to choose the best therapy. Currently focusing on mutations in EGFR and other lung cancer drivers. Working closely with the Molecular Tumor Board at the UMCG #umcg and patient organizations across Europe.
Supporting the clinical decision-making process to choose the best available therapy for patients.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
![]() ITC Europe Insurance, Events Services | ITC Europe Insurance, Events Services | Other 31 May 2024 | |